Introduction
Uveitis (intra-ocular inflammation), a leading cause of vision loss in the western world [1, 2] , exists as an isolated condition or can occur as a manifestation of some systemic autoimmune diseases. Approximately 10% of cases of severe vision loss are thought to be attributed to autoimmune uveitis [3] . While the importance of autoreactive T cells is well accepted in autoimmune uveitis it is also known that innate signals, e.g. initiated by microbial detection, are required to generate pathogenic cellular responses. In classical experimental autoimmune uveitis (EAU), mice immunized with the retinal antigen, interphotoreceptor retinoid binding protein (IRBP), in the presence of complete Freund's adjuvant (CFA) containing Mycobacterium tuberculosis, develop T cell-mediated intra-ocular inflammation that clinically and pathologically resembles human uveitis [4] . T helper type 1 (Th1) and Th17 responses are known immunopathological mechanisms in EAU [4] , yet little is known about the innate receptors that initiate this disease. To date, research on innate receptors in the eye has focused primarily on the contribution of Toll-like receptors (TLRs) to a wide range of ocular diseases. In ocular autoimmunity, as modelled in EAU, TLRs have been reported to play redundant roles, as mice deficient for TLR-2, 23, 24 or 29 [as well as double knock-out (KO) mice] develop EAU comparable to their wild-type (WT) counterparts [5, 6] . Studies should therefore be broadened to include consideration of other innate receptor families, such as C-type lectin receptors (CLRs) or nucleotidebinding oligomerization domain-like (NOD) receptors (NLRs), which have emerged as essential factors in host defence against microbes, but whose dysregulation has also been linked with inflammatory disease [7] . In the proposed paradigm, where autoimmune disease develops as a result of complex interactions between individual genes and the environment (e.g. microbes, toxins, etc.), further exploration of innate receptor function in autoimmune uveitis is warranted.
The CLR family of immune sensors constitute an integral part of host defence against fungal infection via their ability to recognize components of the carbohydrate-rich cell walls of fungi, such as Candida spp. or mycobacteria [8] [9] [10] . Several well-studied CLRs, including Dectin-1, Dectin-2 and Mincle, are known to elicit inflammatory responses through the adaptor molecule caspase-associated recruitment domain adaptor 9 (Card9) [11] . Interestingly, Mincle and its associated Card9-coupled signalling axis were identified recently as a key pathway in the development of EAU [12] . Dectin-1 has also been implicated in EAU [13] , thereby supporting an autoimmunitypromoting function for CLR family members in events that underlie break in tolerance and development of uveitis.
Aside from Dectin-1, which directly activates the protein tyrosine kinase Syk, other CLRs (e.g. Mincle, Dectin-2, Dectin-3) associate with FcRg in order to activate spleen tyrosine kinase (Syk) and subsequent signal transduction mediated by the adaptor molecule Card9. Assembly of a multi-protein complex involving Card9, Bcl10 and mucosa-associated lymphoid tissue (Malt1) is required for activation of mitogen-activated protein kinase (MAPK)-and nuclear factor (NF)-jB-mediated transcription of a network of genes important for generation of Th1 and Th17 responses [14] . While the Card9-activating CLRs may have differential roles in infection, Card9 expression appears to be absolutely critical for host defence against fungal and mycobacterial infection [15, 16] . Indeed, patients with mutations in CARD9 succumb to candidaemia [17, 18] , an observation which has been investigated at a functional level in Card9-deficient mice infected with Candida albicans [16] . Conversely, dysregulation of CARD9 also appears to be related to immune dysfunction, as it has been identified as a major genetic susceptibility determinant in systemic autoimmune diseases [19, 20] . It is thus interesting to consider a central Card9 pathway that exists at a pivotal intersection between microbial sensing and autoimmune disease. These collective observations led us to postulate that fungi could provide sufficient innate cues to elicit autoimmune uveitis via Card9 activation.
C. albicans is a commensal organism found in harmless association with humans, but can be pathogenic in immunocompromised individuals. However, here we report that innate cues provided solely by C. albicans or another commensal fungus (Saccharomyces cerevisiae) are capable of promoting IRBP-triggered autoimmune uveitis in immunocompetent mice akin to classical EAU through a Card9-dependent mechanism. Conceptually, this observation is interesting because it uncovers a previously unconsidered capacity for commensal fungi to promote autoimmunity akin to that of mycobacteria-containing complete Freund's adjuvant (CFA), a commonly used adjuvant for induction of EAU as well as other experimental autoimmune disease models. Moreover, the fungal-promoted form of uveitis is initiated by activation of Dectin-2, rather than Mincle or Dectin-1, and a-mannan sufficiently replicates the uveitis phenotype induced by C. albicans via a Dectin-2/Card9-coupled mechanism. This report extends our understanding of innate receptors in ocular autoimmunity beyond TLRs to include CLRs, thereby revealing the potential for fungal-derived components as environmental triggers of autoimmune uveitis. Our data, along with those of others, point to the Card9 pathway as an important mechanism in the control of immune tolerance and autoimmunity, a concept that could influence how we approach the study of autoimmune diseases.
Materials and methods

Mice
B10.RIII and C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). C57BL/6 mice lacking expression of Card9, Mincle, Dectin-2 and Dectin-1 (encoded by Card9, Clec4e, Clec4n, Clec7a, respectively) have been described [8] [9] [10] 12, 21] . Littermate controls were used to generate wild-type (WT) and homozygous null mice, and all animals were bred in-house under specific pathogen-free (SPF) conditions at the VA Portland Health Care System. Mice aged between 8 and 12 weeks were used in experiments. All studies were carried out in accordance with the US Department of Health and Human Services Guide for the Care and Use of Laboratory Animals, and were performed under institutional protocols approved at the VA Portland Health Care System.
Induction of autoimmune uveitis
Induction of ocular autoimmunity was modelled after the classical model of EAU which employs CFA [12, 22] . Here, mice were immunized subcutaneously (s.c.) with 200 ml of an emulsion (1 : 1 v/v) of IRBP [125 lg purified IRBP 1 300 lg IRBP [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] peptide (Anaspec, Fremont, CA, USA)] and IFA containing 2Á5 mg/ml (or $1Á5 3 10 7 cells/ mouse) of the fungal agonists: heat-killed C. albicans (HKCA; ATCC 10231; Invivogen Carlsbad, CA, USA), heat-killed S. cerevisiae (HKSC; ATCC 32119; Invivogen), a-mannan from C. albicans, as described previously [23, 24] , or purchased (Sigma, St Louis, MO, USA). In the case of the highly susceptible B10.RIII strain, mice were immunized with 25 mg IRBP 161-180 peptide emulsified in fungal-supplemented incomplete Freund's adjuvant (IFA) without pertussis toxin. For comparison, some studies included induction of EAU as per standard methods using CFA (Sigma) and 2Á5 mg/ml M. tuberculosis (H37RA; Voigt Global Distribution Inc./Difco, Lawrence, KA, USA) [12] or with IFA reconstituted with the mycobacterial cell wallderived products: trehalose-6,6'-dibehenate (TDB, a synthetic analogue of mycobacterial cord factor; InvivoGen, San Diego, CA, USA), peptidoglycan (PGN; InvivoGen) and muramyl dipeptide (MDP; Bachem, Torrance, CA, USA).
Evaluation of clinical and histopathology of uveitis
Clinical fundus (posterior eye) images were acquired from live, anaesthetized mice by topical endoscopic fundus imaging (TEFI), and the severity of inflammation was graded on a scale of 0-4 [12] , as detailed previously [12] . At the termination of studies, eyes were harvested and ocular histopathological changes were scored for severity on a scale of 0-4 [12] . The numbers of leucocytes infiltrating the anterior chamber and vitreous cavity were counted from histological sections. All scoring and enumeration were conducted in a masked fashion. Representative images acquired (at 3200 original magnification).
Multiplex quantitative real-time-polymerase chain reaction (RT-PCR)
Dissected retinas from both eyes were pooled (n 5 6 mice/ condition). Total RNA was extracted (RNeasy kit; Qiagen, Valencia, CA, USA) and cDNA was synthesized (reverse transcription kit; Applied Biosystems, Foster City, CA, USA). Transcripts were analysed using a multiplex quantitative RT-PCR (RT 2 
Profiler
TM PCR Gene Expression Assay kit; SABiosciences, Frederick, MD, USA) and the PRISM V R Sequence Detection system (Applied Biosystems), as described previously [12] . Array results are representative of four independently performed experiments, with a total of 24 mice/condition.
Antigen-recall assay of Th17 response-related cytokine production
To evaluate the antigen-specific T helper type 17 (Th17) cellular response, single-cell suspensions prepared from spleens harvested 14 days post-immunization were stimulated, as reported previously [12] . Briefly, splenocytes were seeded in round-bottomed, 96-well tissue culture plates (1Á5 3 
Statistical analysis
For quantitative RT-PCR, conditions were compared using analysis of variance (ANOVA) with Tukey-Kramer's post-hoc test (Prism; GraphPad Software, San Diego, CA, USA). For non-parametric data (i.e. clinical and histopathology scores), the Mann-Whitney U-test (two-tailed) was used for comparison testing. All experiments were repeated independently. Results are presented as mean 6 standard error of the mean (s.e.m.) and P < 0Á05 was considered significant.
Results
C. albicans-derived signals promote autoimmune uveitis
In light of the recently identified importance for the Card9-signalling pathway in induction of classical EAU [12] , we hypothesized that fungi recognized by CLRs could elicit autoimmune uveitis similarly via a Card9-mediated mechanism. To explore this postulate, we first tested whether substitution of mycobacteria with fungi could elicit ocular autoimmunity. Mice were immunized with IRBP in IFA (devoid of mycobacteria) that was supplemented with C. albicans instead. Clinical monitoring by fundus imaging revealed uveitis onset 7-14 days following immunization that continued to worsen up to 21 days (Fig. 1a) . This IRBP-dependent uveitis, which first appeared at and around the optic nerve head (arrowhead; Fig. 1b) , progressed along the blood vessels (i.e. retinal vasculitis) and encompassed larger areas of retinal lesions over time (Fig. 1b) . Histopathology corroborated the clinical findings (Fig. 1c,d ) and revealed pronounced pathological features, including retinal structural damage (i.e. folding), vasculitis (green asterisk, Fig. 1d ) and perivascular exudates in the ganglion cell layer (GCL). Granulomatous-like inflammation in the neural retina was observed consistently within the inner and outer nuclear layers (INL and ONL), as well as the retinal pigmented epithelial (RPE) layer. Extensive chorioretinal infiltrates were also observed frequently with subretinal haemorrhage. Leucocyte infiltration into the intraocular cavities, an additional parameter of uveitis, was increased significantly in the vitreous of the posterior segment (PS) and aqueous humour of the anterior segment (AS) (Fig.  1e) . Importantly, control animals immunized with adjuvant alone (C. albicans-containing emulsion without IRBP) did not show any clinical or histopathological evidence of uveitis ( Fig. 1) , thereby underscoring the combinatorial requirement for innate signals provided by fungi and autoantigen in eliciting uveitis.
Fungal-promoted uveitis requires Card9 but is independent of Mincle
Sensing of cord factor (or trehalose-6,6-dimycolate, TDM), a constituent of M. tuberculosis cell wall and immunostimulatory component of CFA [25] , by the CLR Mincle is an important factor in host defence against M. tuberculosis infection [26] . Mincle is also reported to be involved in the detection of C. albicans [10] , although the identity of the C. albicans ligand(s) remain(s) unknown. As Mincle was identified previously as a CLR responsible in activation of a Card9-mediated mechanism in classical EAU [12] and the C. albicans-promoted uveitis observed here has pathological features and kinetics similar to classical EAU, we theorized that a similar mechanism, involving Mincle/ Card9-coupled signalling, would be functionally important in fungal-promoted uveitis. Contrary to our postulate, Mincle-deficiency had a negligible effect on fungalpromoted uveitis, as evaluated both clinically and histopathologically (Fig. 2a,c) . The protective effect of Mincle deficiency as reported [12] , however, was reproduced with IRBP-immunization using CFA (Supporting information, Fig. S1a ).
Nonetheless, we found Card9 to be a requirement for induction of fungal-promoted uveitis, as disease severity was reduced dramatically in the absence of Card9 expression (Fig. 2b,c) . Most clinical and histological disease features were attenuated in Card9-deficient mice relative to WT, although we noted that some mild inflammation surrounding optic nerve and blood vessels remained (Fig.  2c) . These results suggest either a redundancy among CLRs and/or involvement of additional CLR(s), apart from Mincle in C. albicans-promoted uveitis. Interstingly, the development of fungal-derived uveitis was not limited to C. albicans, because similar results were obtained in studies using another commonly encountered fungus, S. cerevisiae (Supporting information, Fig. S1b,c) . Card9-deficiency also ameliorated S. cerevisiae-induced uveitis, demonstrating the central role for Card9 in promotion of ocular autoimmunity in the context of fungi.
The Dectin-2/Card9-coupled signalling axis promotes autoimmune uveitis
The above data underscore the central importance of the Card9 pathway in induction of ocular autoimmunity, whether promoted by fungi or mycobacterial triggers. They also suggest that signal activation may originate from unique CLRs apart from Mincle. The Card9-coupled CLRs Dectin-1 and Dectin-2 recognize b-1-3-glucan-containing and high mannose-based polysaccharides, respectively, both of which comprise a large portion of the cell wall of C. albicans and many other fungi [9, 27] . We have observed unique baseline protein expression profiles among the CLRs in naive murine ocular tissues (Fig. 3a) , with Dectin-2 expressed at considerably higher levels than Dectin-1 or Mincle within the retina (the primary tissue target in IRBP-induced uveitis). To address whether either of Dectin-1 or Dectin-2 might be involved in triggering fungal-uveitis, we evaluated uveitis severity in single receptor knock-out (KO) mice. Our data indicate that C. albicans-promoted uveitis occurs independently of Dectin-1 expression, as evaluated both clinically and histopathologically (Fig. 3b,c) , suggesting either a redundant or a non-essential role for Dectin-1 in C. albicans-promoted uveitis. However, uveitis was reduced significantly in Dectin-2 KO mice based on both clinical and histopathological assessment (Fig. 3d,e) , indicating a novel role for Dectin-2 in the promotion of uveitis. In contrast to fungal-derived uveitis in WT mice, Dectin-2 KO mice exhibited a marked reduction in retinal folding, photoreceptor destruction and granulomatous inflammation within the ONL and RPE layers. Clinical fundus imaging of these Dectin-2-deficient mice revealed residual inflammation seen primarily along the retinal vasculature (indicated by a green asterisk in the fundus image; Fig.  3e ), which is a consistent pathological feature observed in fungal-derived uveitis in WT mice [green star, haematoxylin and eosin (H&E)-stained histology image; Fig. 3e ]. This indicates a residual Dectin-2-independent mechanism in the pathogenesis of fungal-derived uveitis. Adjuvant-injected control mice of either genotype showed no detectable histopathological or clinical signs of uveitis (n 5 6 mice/genotype; data not shown).
Collectively, the above data indicate that despite a shared ability among these CLRs to recognize fungal cell components and signal by way of Card9, Dectin-2, but not Dectin-1 or Mincle, plays a hitherto unrecognized role in C. albicans-dependent uveitis. To investigate further the ability of Dectin-2 in promotion of ocular autoimmunity, we explored whether uveitis could be reproduced using the recently identified Dectin-2 agonist, a-mannan [9] . Initially, the ability of a-mannan to elicit IRBP-induced uveitis was screened in B10.RIII mice, a strain that is known to be highly susceptible to EAU. Mice immunized with IRBP in conjunction with purified a-mannan (in lieu of intact C. albicans) developed robust uveitis (Fig. 4a) , which was comparable to that promoted by C. albicans. Interestingly, we noted that the capacity of a-mannan to elicit ocular autoimmunity was similar to that of CFA (used in classical EAU), and was significantly more potent than mycobacterial agonists TDB, peptidoglycan (PGN) or muramyl dipeptide (MDP), all of which have been regarded previously as the responsible immunostimulants of CFA adjuvant. Negative control mice immunized with a-mannan in IFA alone (in the absence of IRBP) did not develop clinical or histopathological signs of uveitis, thereby demonstrating requirement for antigen.
The interaction between a-mannan and Dectin-2 in induction of uveitis was evaluated further using Dectin-2 KO mice (Fig. 4b,c) . In contrast to uveitis promoted by a-mannan in WT mice, uveitis was attenuated significantly in Dectin-2 KO mice, as determined by clinical and histopathological scoring (Fig. 4b,c) , thereby signifying the importance of a-mannan in activating Dectin-2 in C. albicans-promoted uveitis. Finally, we determined whether the uveitis promoted by a-mannan/Dectin-2 interaction also required Card9. Indeed, Card9 deficiency ameliorated uveitis significantly by both clinical and histopathological measures (Fig. 4b,c) . Interestingly, the residual vessel damage and vasculitis was again noted in Dectin-2 KO mice (depicted in fundus and histology images; Fig. 4c , green asterisks), indicating a potential for a-mannan to elicit vasculitis via a Dectin-2-independent mechanism. Collectively, these data support the ability of a-mannan to promote development of autoimmune uveitis, which involves a Dectin-2/Card9-coupled mechanism.
The Th17 response is a key aspect of host defence against fungal infection in which the Card9-pathway mediates transcription of cytokines and chemokines that promote Th17 differentiation [14] . The flip-side is that the Th17 response has also been established as a pathogenic mechanism that drives autoimmune uveitis [4] . To gain further insight into the extent to which polarizing factors associated with the Th17 response might be induced in fungalpromoted uveitis, we examined the transcriptional response in the retina, focusing particularly on a group of previously identified Card9-controlled signatures [12] . Examination of retinas dissected from mice with fungalpromoted uveitis revealed substantial induction of a number of cytokines and chemokines related to promotion of Th17 responses (Fig. 4d) , as well as factors related to microbial detection such as complement components C3 and C5aR, TLRs and the NOD-like receptor (NLR) family member Nlrp3. Notably, genes encoding CLRs such as Mincle (Clec4e), Dectin-1 (Clec7a) and Dectin-2 (Clec4n) were all highly up-regulated in retinas of immunized mice. Using antigen-recall assays, we next examined the extent to which activation of the Dectin-2/Card9-coupled axis elicits an IRBP-specific Th17-associated response (Fig. 4e) . Antigen-stimulated splenocytes showed a significant increase in IL-17A production compared to media controls. Moreover, consistent with the marked reduction in uveitis, Card9 deficiency resulted significantly in reduced IRBPspecific induction of IL-17. These data support a role for the Dectin-2/Card9-coupled pathway in promotion of a Th17 cellular response in uveitis. Fig. 4 . Activation of the Dectin-2/Card9 coupled signalling axis promotes autoimmune uveitis. B10.RIII mice were immunized with interphotoreceptor retinoid binding protein (IRBP) emulsified in incomplete Freund's adjuvant (IFA) supplemented with a-mannan and uveitis was scored from histological sections (a). For comparison, mice were also immunized with heat-killed Candida albicans (HKCA), complete Freund's adjuvant (CFA) or the mycobacterial-derived products trehalose-6-6-dibehenate (TDB), peptidoglycan (PGN) or muramyl dipeptide (MDP). An asterisk (*) indicates significance compared to CFA-immunized mice (n 5 10 mice/group combined from two independent experiments). To determine the specific role(s) for Dectin-2 or Card9 in a-mannan-induced uveitis, disease severity was evaluated clinically and histopathologically in knock-out (KO) mice (b,c). Asterisk (*) indicates significance compared to wild-type (WT) mice while # indicates significance between Dectin-2 and Card9 KO mice (n 5 24 mice/group combined from three independently performed experiments). 
Discussion
The discovery of innate receptors such as TLRs has revolutionized our understanding of the mechanisms underlying microbial sensing and host defence. However, how innate receptor systems might be involved in autoimmunity remains poorly understood. Here, we present data that: (i) reveals a previously unappreciated capacity for fungi to promote development of autoimmune uveitis, (ii) identifies the CLR Dectin-2 as a critical receptor and (iii) affirms Card9 as a central signalling pathway for promoting uveitis and Th17 responses. Together, this report sheds light onto microbial-host interactions in autoimmunity and provides a novel conceptual paradigm within which we can approach future exploration that could lead to the development of alternative therapies for autoimmune disease of the eye or other organs.
These data reveal a novel role for Dectin-2 in its ability to promote autoimmune uveitis. We noted a marked upregulation in genes encoding Card9-activating CLRs (Dectin-1, Dectin-2 and Mincle) within the retina in fungal-promoted uveitis. While the baseline protein expression of CLRs in retinas of naive mice appeared to vary, Dectin-2 expression was expressed constitutively (Fig. 3a) . The cellular source(s) of CLRs such as Dectin-2, which function in uveitis remain to be determined, but our observations support consideration of Dectin-2 in neural tissues such as the eye or brain. Retinal expression of Dectin-2 could be attributable to resident immune-related cells (e.g. microglia, astrocytes), similar to what has been observed for Dectin-2 expression in microglia in the brain [28] . It is also worthwhile to consider expression and function of Dectin-2 in non-myeloid cells, as has been reported recently for Mincle in the case of ischaemic brain injury [29] . As CLRs are known to be expressed predominantly on myeloid cells [14] , ocular function of Dectin-2 during uveitis could be mediated further by peripheral dendritic cells during priming or by phagocytes such as neutrophils and macrophages that infiltrate the eye during uveitis.
Few studies have examined the biological function of CLRs such as Dectin-2 in the context of autoimmunity. In experimental autoimmune encephalomyelitis (EAE), a model for central nervous system (CNS) autoimmunity that shares immunological mechanisms with EAU, it was reported recently that Dectin-2 promoted autoimmunity [30] , which is in line with our present observation in uveitis. Collectively, their report and ours support Dectin-2 as a CLR important to human health, and further studies are warranted in non-CNS-related autoimmune models such as experimental arthritis, particularly given the association between polymorphisms in Clec4n (gene encoding Dectin-2) and rheumatoid arthritis [31] . It is also interesting to consider how distinct microbial cues could elicit differential CLR activation. For example, our prior work in classical EAU (using CFA) demonstrated a role for Mincle, but not Dectin-2 [12] . This contrasts the present study on fungal-promoted uveitis, wherein Mincle was not involved. In terms of other experimental models of autoimmunity, Dectin-1 has been identified as an important inducer of arthritis in the genetically predisposed SKG strain of mice [32] . The differential roles of individual Card9-associated CLRs, be they activated by mycobacterial and/or fungalderived signals, in distinct autoimmune-mechanisms, will be an interesting avenue of future research.
While the specific cellular and molecular mechanisms underlying the autoimmunity-promoting effects of the Dectin-2/Card9-pathway or of a-mannan were not explored in detail here, in-vitro studies by others have demonstrated the requirement for Dectin-2 in cytokine responses [e.g. increased tumour necrosis factor (TNF), IL-6, IL-1b, IL-23 and IL-10] triggered by a-mannan [9] . In the case of Dectin-2, the Card9 signalling pathway, which is initiated by FcRg-coupled Syk and mediated by the multiprotein complex of Bcl10 and Malt1, leads to activation of MAPK-and NK-jB-mediated transcription, activation of the Nlrp3 inflammasome and production of reactive oxygen species [14] , all of which are thought to be important in optimization of the Th17-mediated anti-fungal immunity. Our data support a central role for a Card9-mediated mechanism, as fungal-promoted uveitis as well as amannan-initiated uveitis were abrogated by Card9 deficiency. Indeed, retinas of fungal-immunized mice showed induction of similar sets of cytokine and chemokine genes that are involved in promotion of Th17 responses, an important aspect of the Card9-coupled signalling axis for controlling fungal infections [14] . Microbial detection genes such as complement components C3 and C5aR were also highly up-regulated, which could be of functional relevance, as anaphylatoxins C3a and C5a have been identified as mediators in classical EAU [33] . Also of note, the enhanced transcription of IL-1-related genes supports the requirement of the IL-1R/myeloid differentiation primary response gene 88 (MyD88)-signalling pathway reported in classical EAU [6] , suggesting that the Nrlp3-inflammasome and downstream biological responses of IL-1 are a principal pathway for induction of ocular autoimmunity in both scenarios. Thus, it seems conceivable that CLR signalling, which has even been shown to regulate IL-17 in a feedforward autocrine fashion in both innate myeloid cells [34] and Th17 cells, could be an important mechanism involved in the breakdown of immunological tolerance that leads to ocular autoimmunity through the Card9 pathway.
Another interesting observation from this study was that a-mannan appeared inherently more potent than the individual mycobacterial components TDB, PGN and MDP and equivalent to that of whole M. tuberculosis in CFA in inducing autoimmune uveitis (Fig 4a) . It would thus be important to understand more clearly the properties of amannan, as it could have ramifications for adjuvant development. As a recently identified Dectin-2 agonist, the biological responses to a-mannan exposure are still being defined, but the observation that injection of a-mannan causes vasculitis in mice is especially interesting [35] given that a-mannan injection, even in Dectin-2 KO mice, has pronounced retinal vasculitis. One interpretation of this would be that a-mannan-mediated effects on endothelial cells are involved in breakdown of the blood-ocular barrier in uveitis. The residual disease in a-mannan-immunized Dectin-2 KO mice would suggest involvement of an additional immune receptor(s) besides Dectin-2 that signals by way of Card9 in the sensing of C. albicans mannoproteins. One putative candidate responsible for these attributes is the newly discovered CLR, Dectin-3, which is capable of forming a heterodimeric complex with Dectin-2 and acting synergistically to promote TNF, IL-6 and IL-17 production to C. albicans [36] . Alternatively, contaminants within the a-mannan preparation could also conceivably activate CLRs-independently of Dectin-2. Further studies examining Dectin-3 among in promotion of ocular autoimmunity would be of significant interest.
In conclusion, this study demonstrates that, irrespective of upstream CLRs, the Card9 pathway is probably positioned at a crossroad between microbial response and autoimmune disease. Different classes of microbes that activate the Card9 pathway, including Mycobacteria or fungi, such as C. albicans or S. cerevisiae (as demonstrated here; Supporting information), have the capacity to provide the innate signals that drive retina-specific T cells in uveitis. Aberrant dysregulation of this pathway could be envisioned in genetically predisposed individuals, such as patients with CARD9 polymorphisms who develop ankylosing spondylitis [19] , a condition that is linked strongly to uveitis. Given the ubiquity of C. albicans in our environment, demonstration of its relevance to disease may be complicated, but a number of observations in patients lend support to the concept of fungi as initiating and/or perpetuating factors in autoimmune disease. Elevated levels of anti-S. cerevisiae antibodies (ASCA) have been documented in systemic inflammatory disorders, including Crohn's disease (another CARD9-linked condition) [20] and Behc¸et's disease [37, 38] . Notably, in Behc¸et's disease, uveitis is a diagnostic criterion [39] , as up to 90% of patients with this condition develop uveitis [40] . The presence of anti-S. cerevisiae antibodies, and by extension T cells reactive to S. cerevisiae, in inflammatory disorders linked strongly with uveitis suggests that fungal elements may serve as important and previously unappreciated antigens capable of causing breaks in ocular-immune tolerance and predisposing individuals to uveitis. Certainly, observations made in autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED) argue for a more direct role for C. albicans in uveitis. This rare autosomal recessive syndrome is caused by a mutation in AIRE [41] and characterized by organ-specific autoimmunity, including uveitis [42, 43] , as well as chronic mucocutaneous candidiasis [41] , suggesting an interaction between fungalinduced pathways and autoimmunity beyond candidiasis.
Remarkable advances have been made in the understanding of immune recognition processes by CLRs during C. albicans infection, but have been relatively limited in the areas of autoimmunity. However, because EAU shares essential immunological mechanisms with other tissuespecific autoimmune disorders, including experimental autoimmune encephalomyelitis, neuritis, arthritis, orchitis and others, these findings expand our understanding of the importance of CLRs in autoimmune disease, whether they are activated by fungi or mycobacteria, and of the central importance of the Card9 pathway in driving retina-specific T cells. Moreover, these findings could influence future basic scientific exploration of mechanisms of autoimmunity using experimental models that have relied historically upon CFA.
